Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,914 | 363 | 46.7% |
| Consulting Fee | $8,125 | 2 | 42.6% |
| Education | $852.13 | 13 | 4.5% |
| Gift | $785.56 | 1 | 4.1% |
| Travel and Lodging | $417.32 | 2 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $5,972 | 22 | $0 (2022) |
| Aytu Bioscience, Inc | $3,255 | 11 | $0 (2020) |
| Astellas Pharma US Inc | $1,594 | 71 | $0 (2024) |
| Teleflex LLC | $1,228 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $1,142 | 48 | $0 (2024) |
| NxThera, Inc. | $828.16 | 3 | $0 (2017) |
| NeoTract Inc. | $676.29 | 12 | $0 (2020) |
| Antares Pharma, Inc. | $443.75 | 27 | $0 (2024) |
| Axonics, Inc. | $436.80 | 5 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $323.51 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,381 | 45 | Axonics, Inc. ($299.20) |
| 2023 | $1,328 | 54 | Astellas Pharma US Inc ($343.57) |
| 2022 | $7,304 | 80 | Acerus Pharmaceuticals Corporation ($5,866) |
| 2021 | $1,704 | 61 | Teleflex LLC ($649.16) |
| 2020 | $993.78 | 29 | NeoTract Inc. ($428.11) |
| 2019 | $3,961 | 43 | Aytu BioScience, Inc ($3,144) |
| 2018 | $652.21 | 30 | Avadel Specialty Pharmaceuticals, LLC ($141.08) |
| 2017 | $1,770 | 39 | NxThera, Inc. ($828.16) |
All Payment Transactions
381 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Medical Urology | ||||||
| 12/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/02/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $160.20 | General |
| Category: Urology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $133.41 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: Oncology | ||||||
| 10/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $21.95 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/27/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $22.42 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: UROLOGY | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $19.68 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 08/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $18.59 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: Oncology | ||||||
| 07/12/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 07/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $30.55 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,338 | 2,225 | $738,905 | $148,114 |
| 2022 | 27 | 1,336 | 2,022 | $676,834 | $142,131 |
| 2021 | 37 | 2,080 | 2,778 | $1.1M | $333,611 |
| 2020 | 35 | 3,460 | 4,144 | $1.2M | $357,932 |
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 257 | 551 | $165,300 | $41,836 | 25.3% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2023 | 53 | 54 | $64,800 | $19,106 | 29.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 47 | 273 | $40,950 | $14,716 | 35.9% |
| J3490 | Unclassified drugs | Office | 2023 | 13 | 138 | $56,290 | $12,466 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $49,385 | $11,928 | 24.2% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 77 | 88 | $79,200 | $11,788 | 14.9% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 76 | 85 | $42,500 | $7,660 | 18.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 25 | 26 | $39,000 | $5,573 | 14.3% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 80 | 89 | $35,600 | $3,917 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 31 | $13,770 | $3,468 | 25.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 19 | $7,790 | $3,053 | 39.2% |
| 11980 | Placement of hormone pellet under skin | Office | 2023 | 11 | 31 | $8,680 | $2,755 | 31.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 19 | 20 | $16,000 | $2,342 | 14.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 178 | 273 | $5,460 | $2,293 | 42.0% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 58 | 59 | $35,400 | $1,517 | 4.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 100 | 124 | $12,400 | $1,164 | 9.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 15 | $3,000 | $1,100 | 36.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 42 | $7,980 | $543.10 | 6.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 105 | 144 | $7,200 | $491.04 | 6.8% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 59 | 60 | $48,000 | $354.43 | 0.7% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 17 | 20 | $200.00 | $44.30 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 269 | 526 | $157,800 | $41,484 | 26.3% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2022 | 47 | 51 | $61,200 | $19,861 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 87 | 87 | $51,765 | $12,518 | 24.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 35 | 217 | $32,550 | $11,716 | 36.0% |
About Dr. Michael Rotman, MD
Dr. Michael Rotman, MD is a Urology healthcare provider based in Lawrence, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649284100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Rotman, MD has received a total of $19,094 in payments from pharmaceutical and medical device companies, with $1,381 received in 2024. These payments were reported across 381 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,914).
As a Medicare-enrolled provider, Rotman has provided services to 8,214 Medicare beneficiaries, totaling 11,169 services with total Medicare billing of $981,788. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Lawrence, NY
- Active Since 07/28/2006
- Last Updated 09/17/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1649284100
Products in Payments
- Natesto (Drug) $9,227
- ERLEADA (Drug) $855.13
- Rezum (Device) $828.16
- UroLift System (Device) $686.31
- XTANDI (Drug) $652.67
- UroLift (Device) $620.73
- Myrbetriq (Drug) $471.79
- Bulkamid (Device) $413.10
- UROLIFT (Device) $403.11
- XYOSTED (Drug) $270.06
- LoFric (Device) $269.12
- Prolaris (Device) $216.98
- MYRBETRIQ (Drug) $199.60
- Erleada (Drug) $194.86
- NOCDURNA (Drug) $181.21
- XIAFLEX (Biological) $174.93
- JATENZO (Drug) $149.14
- Noctiva (Drug) $141.08
- UroLift ATC System (Device) $138.99
- PYLARIFY (Drug) $135.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Lawrence
Douglas Klingler, M.d, M.D
Urology — Payments: $3,697
Dr. Jason Grotas, Md, MD
Urology — Payments: $3,646
Dr. Ryan Didde, Md, MD
Urology — Payments: $1,890
Dr. Jon Heeb, M.d, M.D
Urology — Payments: $968.35
Paul Hochsztein, Md, MD
Urology — Payments: $348.60
Ernesto Lopez, M.d, M.D
Urology — Payments: $58.39